-
EP3735988
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3735988
| EP3735988 - SUBLINGUAL FILMS [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 01.01.2026 Database last updated on 08.04.2026 | |
| Former | Grant of patent is intended Status updated on 18.12.2025 | ||
| Former | Examination is in progress Status updated on 19.11.2025 | ||
| Former | Grant of patent is intended Status updated on 17.07.2025 | ||
| Former | Examination is in progress Status updated on 10.02.2023 | ||
| Former | Request for examination was made Status updated on 09.10.2020 | Most recent event Tooltip | 06.02.2026 | Change - divisional application(s) | published on 11.03.2026 [2026/11] | Applicant(s) | For all designated states Sumitomo Pharma America, Inc. 84 Waterford Drive Marlborough, MA 01752 / US | [2025/27] |
| Former [2025/22] | For all designated states Sumitomo Pharma America, Inc. 84 Waterford Drive Marlborough, MA 01752 / US | ||
| Former [2020/46] | For all designated states Sunovion Pharmaceuticals Inc. 84 Waterford Drive Marlborough, MA 01752 / US | Inventor(s) | 01 /
BRYSON, Nathan, John 99 Glen Road, Apt. 1 Toronto, Ontario M4W 2V8 / CA | 02 /
GIOVINAZZO, Anthony, John 1302 Kestell Boulevard Oakville, Ontario L6H 0B9 / CA | 03 /
BARNHART, Scott, David 1820 Shawan Lane York, PA 17406 / US | 04 /
KOONS, Michael, Clinton 272 Point Circle York, PA 17406 / US | [2020/46] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2020/46] | Application number, filing date | 20167201.1 | 16.12.2011 | [2020/46] | Priority number, date | US201042385810P | 16.12.2010 Original published format: US 42385810 P | US201161483864P | 09.05.2011 Original published format: US 201161483864 P | [2020/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3735988 | Date: | 11.11.2020 | Language: | EN | [2020/46] | Type: | B1 Patent specification | No.: | EP3735988 | Date: | 04.02.2026 | Language: | EN | [2026/06] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.10.2020 | Classification | IPC: | A61K47/02, A61K9/70, A61K47/14, A61K47/38, A61K31/4045, A61K31/485, A61K31/473, A61K31/381, A61K31/428, A61K31/4415, A61K31/48, A61K31/4985, A61K31/506, A61K45/06, A61P25/16, A61P43/00, A61F13/00 | [2020/46] | CPC: |
A61F13/00063 (EP,IL,US);
A61K9/7007 (IL,US);
A61K9/006 (EP,IL,KR,US);
A61J1/03 (IL,US);
A61J7/0053 (IL,US);
A61K31/381 (EP,IL,US);
A61K31/4045 (EP,IL,US);
A61K31/428 (EP,IL,US);
A61K31/4415 (EP,IL,US);
A61K31/473 (EP,IL,KR,US);
A61K31/48 (EP,IL,US);
A61K31/485 (EP,IL,US);
A61K31/4985 (EP,IL,US);
A61K31/506 (EP,IL,US);
A61K45/06 (EP,IL,US);
A61K47/02 (EP,IL,US);
A61K47/10 (IL,US);
A61K47/12 (IL,US);
A61K47/14 (EP,IL,US);
A61K47/183 (IL);
A61K47/22 (IL,US);
A61K47/36 (IL,US);
A61K47/38 (EP,IL,US);
A61K9/209 (IL,US);
A61P25/16 (EP,US);
A61P43/00 (EP);
B29C39/18 (IL,US);
B29C39/38 (IL,US);
B29C43/305 (IL,US);
B29C43/52 (IL,US);
B29C65/70 (IL,US);
B29C66/45 (IL,US);
B65D65/38 (IL,US);
A61K2300/00 (IL,US);
B29K2001/00 (IL,US);
B29L2007/008 (IL,US);
| C-Set: |
A61K31/4045, A61K2300/00 (EP);
A61K31/473, A61K2300/00 (EP);
A61K31/485, A61K2300/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/46] | Title | German: | SUBLINGUALE FILME | [2020/46] | English: | SUBLINGUAL FILMS | [2020/46] | French: | FILMS SUBLINGUES | [2020/46] | Examination procedure | 31.03.2020 | Examination requested [2020/46] | 10.05.2021 | Amendment by applicant (claims and/or description) | 14.02.2023 | Despatch of a communication from the examining division (Time limit: M06) | 23.08.2023 | Reply to a communication from the examining division | 03.07.2025 | Cancellation of oral proceeding that was planned for 08.07.2025 | 08.07.2025 | Date of oral proceedings (cancelled) | 17.07.2025 | Communication of intention to grant the patent | 17.11.2025 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 17.11.2025 | Fee for grant paid | 17.11.2025 | Fee for publishing/printing paid | 18.12.2025 | Communication of intention to grant the patent | 23.12.2025 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP11848299.1 / EP2651357 | Divisional application(s) | EP26156140.1 | Fees paid | Renewal fee | 31.03.2020 | Renewal fee patent year 03 | 31.03.2020 | Renewal fee patent year 04 | 31.03.2020 | Renewal fee patent year 05 | 31.03.2020 | Renewal fee patent year 06 | 31.03.2020 | Renewal fee patent year 07 | 31.03.2020 | Renewal fee patent year 08 | 31.03.2020 | Renewal fee patent year 09 | 28.12.2020 | Renewal fee patent year 10 | 27.12.2021 | Renewal fee patent year 11 | 27.12.2022 | Renewal fee patent year 12 | 27.12.2023 | Renewal fee patent year 13 | 27.12.2024 | Renewal fee patent year 14 | 29.12.2025 | Renewal fee patent year 15 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [PXI] WO2010144817 (ADAGIO PHARMACEUTICALS LTD et al.) | [A] WO9826763 (LOHMANN THERAPIE SYST LTS et al.) | [A] WO2006120412 (AMARIN PHARMACEUTICALS IRELAND et al.) | [A] US2008124381 (BARNHART SCOTT D et al.) | [A] JP2005263704 (KYUKYU YAKUHIN KOGYO KK et al.) | by applicant | WO03080074 | US4687773 | WO2005099702 | WO2009052421 | US2006210610 | US2001006677 | US4746508 | US4540602 | US5145684 | US5518187 | US5718388 | US5862999 | US5665331 | US5662883 | US5560932 | US5543133 | US5534270 | US5510118 | US5470583 | US6976647 | EP0498482 | US3559895 | US61423858 | US201161483864 | VAN LAAR T., CNS DRUGS, vol. 17, 2003, pages 475 | KOLLER ET AL., NEUROLOGY, vol. 62, no. 4, 2004, pages S22 - S31 | DEFFOND ET AL., J. NEUROL. NEUROSURG. PSYCHIATRY, vol. 56, 1993, pages 101 | PRIETZ ET AL., J. NEUROL. NEUROSURG. PSYCHIATRY, vol. 65, 1998, pages 709 | J. MED. CHEM., vol. 19, 1976, pages 717 | ATKINSON ET AL., J. PHARMA. SCI., vol. 65, 1976, pages 1685 | CAMPBELL ET AL., NEUROPHARMACOLOGY, vol. 21, 1982, pages 953 | KEARY, CARBOHYDRATE POLYMERS, vol. 45, 2001, pages 293 | REHSE ACHIVES DES PHARMAZIE, vol. 7, 1969, pages 488 |